| Literature DB >> 26732583 |
Neda Shahmohammadibeni1, Simin Rahimi-Aliabadi2, Javad Jamshidi3, Babak Emamalizadeh2, Hossein Ali Shahmohammadibeni4, Alireza Zare Bidoki5, Haleh Akhavan-Niaki1, Hajar Eftekhari1, Shokoufeh Abdollahi6, Mahmoud Shekari Khaniani7,8, Mahnaz Shahmohammadibeni1, Atena Fazeli2, Marzieh Motallebi2, Shaghayegh Taghavi2, Azadeh Ahmadifard2, Amir Ehtesham Shafiei Zarneh2, Monavvar Andarva2, Tahereh Dadkhah1, Ehteram Khademi1, Elham Alehabib2, Mahnoosh Rahimi2, Abbas Tafakhori9, Minoo Atakhorrami2, Hossein Darvish10.
Abstract
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder. Both genetic and environmental factors are involved in the etiology of the disease. Many studies have revealed the susceptibility genes and variations for PD which need further confirmation. Here we evaluated the association of variations in SNCA, HUSEYO and CSMD1 genes with PD. A case-control study was conducted with 489 PD patients and 489 healthy controls. DNA was extracted from peripheral blood of all subjects and rs356220 and rs11931074 in SNCA, rs2338971 in HUSEYO and rs12681349 in CSMD1 were genotyped using PCR-RFLP method. The genotypes and allele frequencies were significantly different between case and control groups for rs356220, rs11931074 and rs2338971 but not for rs12681349. We provided further evidence that rs356220 is associated with increased risk of PD supporting previous studies in Caucasian-based and Japanese populations. The association of rs11931074 with decreased risk of PD was also significant. This study revealed the first evidence of the association of rs2338971 with increased risk of PD in the Iranian population. Nevertheless, these findings need further validation via more replication studies.Entities:
Keywords: CSMD1; HUSEYO; Iranian; Parkinson’s disease; Polymorphism; SNCA
Mesh：
Substances：
Year: 2016 PMID： 26732583 DOI： 10.1007/s10072-015-2420-x
Source DB: PubMed Journal: Neurol Sci ISSN： 1590-1874 Impact factor: 3.307